Immergo Labs Accepted Into NVIDIA Inception
SANTA CRUZ, CA – June 19, 2025 – Immergo Labs, a pioneer in extended reality (XR) solutions for healthcare, yesterday announced its acceptance into NVIDIA Inception, a program designed to nurture cutting-edge startups. This collaboration will significantly accelerate Immergo Labs' mission to transform physical therapy through its innovative telehealth platform.
Immergo Labs is revolutionizing rehabilitation by enabling live physical therapy sessions with embodied 3D avatars and guided remote exercise programs. The platform, powered by Immergo Labs' patented AI biomechanics system, provides full-body movement tracking using readily available VR headsets or AR glasses.
“We are thrilled that Immergo was invited to join the NVIDIA Inception Program,” said Aviv Elor, Immergo Co-Founder, President, and Chief Research Officer. “This partnership will accelerate our development as we enhance our biomechanics AI models with advanced GPU capabilities. The program provides invaluable access to cutting-edge technologies and expertise that will help us deliver more precise, objective movement metrics to support patients and providers throughout the recovery journey.”
Through NVIDIA Inception, Immergo Labs will gain access to critical resources, including:
Advanced GPU Acceleration: Leveraging NVIDIA's powerful GPUs will enhance the performance and efficiency of Immergo Labs' AI models.
Go-to-Market Support: The program will provide invaluable guidance and resources for navigating the healthcare technology market.
Algorithm Optimization: Immergo Labs will optimize its real-time biomechanics tracking algorithms, further enhancing the precision and effectiveness of its platform.
Expert Collaboration: The company will have the opportunity to collaborate with industry-leading experts and AI-driven organizations within the NVIDIA ecosystem.
This collaboration underscores Immergo Labs' commitment to delivering accessible, engaging, and effective physical therapy solutions to a broader audience.
